Articles

Discover our latest study on Bifidobacterium longum KAPB042’s ability to protect the intestinal barrier at ESPGHAN 2023 16 May 2023 – 2 min read We’re… Read More »Explore our latest study at ESPGHAN 2023 revealing the intestinal barrier protection of our Bifidobacterium strain

AB-LIFE probiotic formulation has recently been approved by the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, Anvisa) as a safe and efficient food supplement to help reduce cholesterol levels.

Meet us at Probiota 2023! 24 January 2023 – 2 min read We’re excited to announce our attendance at the IPA World Congress + Probiota… Read More »Meet us at Probiota 2023!

A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.

Meet us at Food ingredients Europe 29 November 2022 – 2 min read We are excited to be exhibiting for the first time at Food… Read More »Meet us at Food ingredients Europe

To offer a preventive, natural solution to Filipinos in risk of high cholesterol, Pharex and AB-BIOTICS have recently launched Biome Lipidec.

We are excited to be attending not one but three events in Asia during the remainder of this year. As part of Kaneka Probiotics, we’re always looking to connect with our customers and partners in the region.

For World Microbiome Day, let’s talk about gut dysbiosis and its detrimental impact in human health.

We are thrilled to announce that our two finalists, AB21® and LipiGO®, have both taken home the crown in their respective categories for this year’s NutraIngredients Awards

Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.